EVH vs. RUM, INTA, CCOI, IDCC, KLIC, ZD, SITM, PRFT, YELP, and SMTC
Should you be buying Evolent Health stock or one of its competitors? The main competitors of Evolent Health include Rumble (RUM), Intapp (INTA), Cogent Communications (CCOI), InterDigital (IDCC), Kulicke and Soffa Industries (KLIC), Ziff Davis (ZD), SiTime (SITM), Perficient (PRFT), Yelp (YELP), and Semtech (SMTC). These companies are all part of the "computer and technology" sector.
Rumble (NASDAQ:RUM) and Evolent Health (NYSE:EVH) are both mid-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, community ranking, dividends and institutional ownership.
Evolent Health received 542 more outperform votes than Rumble when rated by MarketBeat users. Likewise, 73.88% of users gave Evolent Health an outperform vote while only 25.00% of users gave Rumble an outperform vote.
In the previous week, Rumble had 20 more articles in the media than Evolent Health. MarketBeat recorded 24 mentions for Rumble and 4 mentions for Evolent Health. Evolent Health's average media sentiment score of 0.28 beat Rumble's score of 0.21 indicating that Rumble is being referred to more favorably in the media.
Evolent Health has higher revenue and earnings than Rumble. Evolent Health is trading at a lower price-to-earnings ratio than Rumble, indicating that it is currently the more affordable of the two stocks.
Evolent Health has a consensus target price of $42.00, indicating a potential upside of 82.05%. Given Rumble's stronger consensus rating and higher possible upside, analysts plainly believe Evolent Health is more favorable than Rumble.
Rumble has a beta of 0.88, suggesting that its stock price is 12% less volatile than the S&P 500. Comparatively, Evolent Health has a beta of 1.57, suggesting that its stock price is 57% more volatile than the S&P 500.
Evolent Health has a net margin of -5.07% compared to Evolent Health's net margin of -161.62%. Rumble's return on equity of 6.90% beat Evolent Health's return on equity.
26.2% of Rumble shares are owned by institutional investors. 72.9% of Rumble shares are owned by insiders. Comparatively, 3.3% of Evolent Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Evolent Health beats Rumble on 11 of the 18 factors compared between the two stocks.
Get Evolent Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for EVH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EVH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Evolent Health Competitors List
Related Companies and Tools
